GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
admin GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read MoreGSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read More